Author

G. Viscido

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:scRNA-seq· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

G. Gambardella· 2 shared S. Pellecchia· 2 shared D. di Bernardo· 1 shared G. M. Nocera· 1 shared M. Franchini· 1 shared R. Arnese· 1 shared S. Brillante· 1 shared S. Carrella· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Gambardella

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Predicting drug response from single-cell expression profiles of tumours

S. Pellecchia, G. Viscido, G. Gambardella, G. Gambardella

This paper introduces DREEP, a method to predict single-cell drug sensitivity from transcriptomic data, validated using cancer cell lines and applied to breast cancer cells to identify targeted drugs.

bioRxiv · Jun 1, 2023Cancer Biology

Single cell lineage tracing reveals subclonal dynamics of anti-EGFR therapy resistance in triple negative breast cancer.

S. Pellecchia, M. Franchini, G. Viscido, R. Arnese, G. Gambardella

The paper uses single-cell lineage tracing and deep learning to study anti-EGFR therapy resistance in TNBC, identifying IGFBP2 as a driver of resistance and predicting afatinib sensitivity.

bioRxiv · Apr 4, 2023Cancer Biology

The VersaLive platform enables pipette-compatible microfluidic mammalian cell culture for versatile applications

G. M. Nocera, G. Viscido, S. Brillante, S. Carrella, D. di Bernardo

The paper introduces a microfluidic platform called VersaLive that enables pipette-compatible cell culture for various applications, improving accessibility and reducing costs.

bioRxiv · Jul 2, 2021 · PreprintBioengineering